Ann: Race-Chaim Sheba FTO Biomarker Collaboration, page-112

Hi Wegian,

In your post above, you mentioned that us retail investor's clueless amateur.

Well I will give you a lesson.

The trading halt, released today, is about our Israel Phase 1b/2 AML trial, which started in August 2021.


But if we do just 5 minutes of research you will find that R.A.C. are also looking at F.T.O.



So next time you decide to shoot from the key board's and write nothing but dribble, do your self the favour and do Due Diligence.

https://www.raceoncology.com/

Know I will wait till the announcement is made on Monday and if the result's are in our favour, then we just might see our share price at this level.



O shit I forgot to mention that next Tuesday R.A.C. has a site meeting.

Do know what that is for, the start of our next trial.


IMHO.

Regard's

Rossi70